AnalyStock.ai

AnalyStock.ai Informations de contact, plan et itinéraire, formulaire de contact, heures d'ouverture, services, évaluations, photos, vidéos et annonces de AnalyStock.ai, Service financier, 229 Rue Saint-Honoré, Paris.

15/01/2026

📈 While JPMorgan, BofA & Wells Fargo crash on credit card fears, BNY Mellon hits ALL-TIME HIGHS

Here's why: BNY doesn't do consumer lending. Zero credit cards. Zero mortgages.

They make money from FEES - custody services for the $59 TRILLION they oversee for institutions.

When government attacks consumer banking → BNY wins 🎯

Q4 beat ✅
Raised margin targets ✅
AI generating $550M in savings ✅

Trading at $122 (16x earnings) - priced for perfection but the defensive moat is real.

Target: $135-145 near-term | $200+ if AI transformation delivers

08/01/2026

📊 INTEL ($INTC): Up 83% This Year - But Should You Buy?

After deep analysis, here's the truth about Intel's $190B comeback bet 👇

💰 CURRENT: $40/share
🎯 12-Month Target: $38-48
🚀 Bull Case (2030): $60-140
📉 Bear Case (2030): $12-25

⚡ WHAT TO WATCH:
✅ Panther Lake launch THIS MONTH
✅ 18A chip performance vs TSMC
✅ External foundry customer wins
❌ Yield problems or delays

💡 THE REALITY:
This isn't the "safe" Intel anymore. It's a high-risk turnaround story. If they nail the foundry transformation → 3× upside. If they fail → 50%+ downside.

Government owns 10%. NVIDIA invested $5B. The next 12 months will tell us everything.

📎 Full analysis with scenarios & catalysts → Link in bio

Your take? Bull 🟢 or Bear 🔴? Comment below 👇

---



*Not financial advice. DYOR.*

23/12/2025

NEWMONT MINING (NEM) - The $110B Gold Giant 🏆⛏️

Gold is absolutely RIPPING right now... and Newmont is cashing in BIG TIME 💰

Here's the breakdown on the world's largest gold producer:

📊 CURRENT STATS:
• Price: $101/share
• Market Cap: $110 Billion
• YTD Performance: +132% 🚀
• Annual Production: 6M oz of gold
• Free Cash Flow: $9.3B (8.5% yield!)

🎯 ANALYSTOCK PRICE TARGETS:
• 12-Month Base: $110-120
• 3-Year Outlook: $180-240
• 2030 Bull Case: $225-360

💎 WHY IT MATTERS:
Newmont sits on 134 MILLION ounces of gold reserves - that's DECADES of production. While gold is up 55% this year, NEM has doubled that return at 132%.

With profit margins at 33% and analysts forecasting gold could hit $5,000-7,000/oz by 2030, this could be one of the cleanest ways to play the precious metals super cycle.

⚠️ THE RISK:
It's ALL about gold prices. If gold corrects back to $2,000-2,400/oz, NEM could pull back to $85-95. But if the gold bull market continues? Sky's the limit.

🔗 Full analystock valuation report with all scenarios, comparables, and risk analysis - link in bio

Are you bullish or bearish on gold? Drop your take below 👇

---

09/12/2025

Arista is becoming the high-speed backbone of the AI revolution. With revenue up 27% YoY, net margins near 40%, and more than $10B in cash, the company continues to deliver exceptional ex*****on.

Yes, the stock trades at a premium (~50× earnings), but the growth profile and AI demand help justify it.
My fair value sits around $150–160, with upside to $170 if capex in AI data centers accelerates. Long term, ANET could reach the $300 range if it remains central to AI networking.

Want the full research report?
Comment ARISTA and I’ll send it to you.

02/12/2025

📊 MONGODB ($MDB): The $27B AI Database Play Everyone's Talking About 🚀

MongoDB just dropped EXPLOSIVE earnings and the stock surged 22% after hours. Here's what you need to know:

💰 THE NUMBERS:
• Q3 Revenue: $628M (+19% YoY)
• Atlas Growth: 30% YoY (their cloud platform)
• Raised FY26 Guidance: $4.76-4.80 EPS (up from $3.64-3.73)
• Free Cash Flow: $140M in one quarter
• Market Cap: ~$27 billion

🤖 THE AI STORY:
MongoDB's vector search technology is becoming THE infrastructure for AI applications. 74% of organizations plan to use integrated vector databases for AI workflows. This isn't just a database company anymore—it's an AI infrastructure play.

🎯 WALL STREET TARGETS:
• Goldman Sachs: $475 (44% upside)
• BofA Securities: $480
• Consensus: Strong Buy from 26 analysts
• Bull Case 2030: $650-850

⚠️ THE RISKS:
Trading at 80x forward earnings—this is EXPENSIVE. One disappointing quarter could trigger a major selloff. Competition from AWS, Azure, and open-source alternatives is intense.

📈 OUR TAKE:
Base case target: $380-420 (12 months)
Bull case if AI adoption explodes: $480-500
Bear case if growth slows: $280-320

MongoDB is positioned at the intersection of cloud computing and AI—two of the biggest tech trends. But at these valuations, ex*****on must be flawless.

Would you buy at current levels? Drop a 🚀 if bullish, 📉 if bearish.

---

⚠️ This is not financial advice. Always do your own research and consider your risk tolerance before investing.

25/11/2025

📊 ABBOTT LABORATORIES ($ABT) - Deep Dive 💉

Is this healthcare giant undervalued? Here's what the numbers say 👇

💰 Current Price: ~$128
📈 Market Cap: $220B
🎯 12-Month Target: $140-150

🔥 WHY IT MATTERS:

✅ FreeStyle Libre (diabetes monitoring) = game changer
✅ Only 2% market pe*******on - HUGE growth runway
✅ Targeting $10B in CGM sales by 2028
✅ 52 YEARS of dividend increases 💎
✅ 500M+ diabetics globally, only 10M using CGMs

📊 THE OPPORTUNITY:

Trading at 23x earnings but growing diabetes business at 20%+ 🚀

With Medicare expansion coming + new partnerships + international growth... the setup looks interesting.

💡 Price Targets:
• 2026: $140-150
• 2028: $170-185
• Bull Case 2030: $180-230+

The market treats Abbott like a boring healthcare stock, but the diabetes tech story could change that 📱

Swipe for full breakdown ➡️

⚠️ NOT FINANCIAL ADVICE | Educational content only | Always DYOR and consult a financial advisor before investing

---

What do you think? Is Abbott positioned to dominate diabetes care? Drop your thoughts below 👇

18/11/2025

⚡ AI IS BREAKING THE POWER GRID—And This $175B Company Is Positioned to Win

For the first time in decades, U.S. electricity demand is SURGING 📈

The culprit? AI data centers consuming massive amounts of power.

Enter NextEra Energy ($NEE):
• America's largest renewable energy producer
• 30 GW renewable pipeline (wind, solar, storage)
• Just partnered with Google to restart nuclear facilities
• Florida's biggest utility (12M customers)

💰 THE NUMBERS:
Current Price: ~$84
Market Cap: $175B
Wall Street Targets: $90-$105 (12-month)
Bull Case (2030): $150-$210

📊 VALUATION:
Trading at 26x forward earnings (premium to utilities)
6-8% projected EPS growth through 2027
2.7% dividend yield + 10% annual dividend growth

⚠️ THE RISKS:
• Premium valuation requires perfect ex*****on
• Interest rate sensitivity
• Regulatory risk in Florida
• Massive capex requirements ($9-10B/year)

🎯 BOTTOM LINE:
Fairly valued at current levels, but MAJOR upside if the AI power boom is real. This is a 3-5 year hold for the energy transition play.

Not financial advice. DYOR 🔍

---

11/11/2025

ROBINHOOD: $116B bet on the future 🎯

Stock up 350% this year. Trading at 57× earnings. Is it genius or madness?

3 things driving the rally:
💰 Crypto revenue +300%
📱 11 products scaling past $100M each
👥 $84 trillion wealth transfer coming

But here's the catch: you're paying 2025 prices for a 2028 company.

Fair value? $70-110.
Current price? $130.

The gap = your bet on flawless ex*****on.

Swipe for the full breakdown 👉

04/11/2025

🚨 GENERAL MILLS AT 10-YEAR LOW 🚨

Is $GIS at $47 a steal or a trap? Let's break down the numbers 📊

✅ THE GOOD:
• 9x P/E ratio (historically 17x)
• 4.5% dividend yield
• 10% free cash flow yield
• Blue Buffalo entering $4B fresh pet food market
• 55 years of consecutive dividends

❌ THE BAD:
• Sales declining 2%
• Private label stealing market share
• Margins compressed to 17%
• Consumer trends shifting away
• GLP-1 drugs threatening snacking categories

💰 THE TARGETS:
📈 Bull Case 2028: $75-80 (60% upside)
📊 Base Case 12M: $53-57 (Wall Street consensus)
📉 Bear Case: $30-35 (downside risk)

THE QUESTION: Is the market overreacting or pricing in structural decline?

At these levels, you're getting paid 4.5% to wait while management executes their turnaround. But patience required ⏰

Drop your thoughts 👇 Turnaround play or value trap?

Not financial advice. DYOR.

30/10/2025

🍔 McDonald’s (MCD) — The Golden Arches face slowing growth but remain a dividend powerhouse.
At ~$306/share, MCD trades ~25x forward earnings with a 2.4% yield.
Base case: $310–335 | Bull: $450 by 2028 | Bear: $260–290
Still the Coca-Cola of fast food — steady, not flashy.

21/10/2025

Marsh & McLennan (MMC) is the world's largest insurance broker—they make billions in commissions helping companies manage risk. Stock dropped from $242 to $195 despite strong earnings because insurance prices are declining. But here's the thing: the world's getting MORE dangerous (cyber, climate, AI risks), which means companies need them MORE. Trading at 20x earnings with 17 years of consecutive margin expansion. Analysts targeting $220-240 (+15-25%). Could be a quality compounder on sale 👀

14/10/2025

CME GROUP: The $270 Question 📊💰

The world's largest derivatives exchange is printing money right now—69% margins, $4B cash flow, record volumes.
But is it a BUY? 🤔

Here's what I'm seeing:

✅ EX*****ON PLAYS:
• Retail traders up 56% (Robinhood partnership coming)
• International: Asia +30%, Europe +15%
• Crypto dominance: Bitcoin, Solana, XRP futures
• Securities clearing = potential $1B+ revenue

📈 PRICE TARGETS: • Base case: $280-$290 (12 months)
• Bull case: $450-$575 (by 2030)
• Current: $270

💡 THE THESIS: CME runs the marketplace where Wall Street hedges risk. More chaos = more hedging = more fees. They're the toll booth on the highway. Right now? Tariffs, Fed moves, geopolitical tension = PEAK hedging demand.

⚠️ THE RISK: If volatility normalizes, volumes could drop hard. My take? They're executing on growth, not just riding the wave. Watch their retail and international numbers closely. What do you think—overvalued or opportunity?

Drop your take below 👇 —

$CME

Adresse

229 Rue Saint-Honoré
Paris
75001

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque AnalyStock.ai publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter L'entreprise

Envoyer un message à AnalyStock.ai:

Raccourcis

Partager

Type